MAPT and tauopathy: In fact, it has been reported that the combination of ScFv and adenovirus system had been used in tauopathies, which demonstrated that anti-tau ScFv could markedly reduce the level of hyperphorylated, aggregated tau in brain and detergent-soluble tau species in vivo [19].